this post was submitted on 12 Nov 2025
1 points (100.0% liked)

China News

93 readers
10 users here now

A community for china news

founded 4 months ago
MODERATORS
 

Chinese drug developer Sichuan Biokin Pharmaceutical has postponed its Hong Kong share listing, which had been scheduled to begin on Monday, as enthusiasm for initial public offerings (IPOs) in the sector may be cooling, according to analysts. The company cited “prevailing market conditions” in a stock-exchange filing on Wednesday and said it was assessing an updated timetable, but did not provide further details. The decision “does not affect the company’s current business”, it added. Listed in...


From China - South China Morning Post via This RSS Feed.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here